Tayek JA - Search Results

1

Oral arginine reduces systemic blood pressure in type 2 diabetes: its potential role in nitric oxide generation.

Huynh NT, Tayek JA. Huynh NT, et al. Among authors: tayek ja. J Am Coll Nutr. 2002 Oct;21(5):422-7. doi: 10.1080/07315724.2002.10719245. J Am Coll Nutr. 2002. PMID: 12356784 Clinical Trial.

2

Safety of Degludec versus Glargine in Type 2 Diabetes.

Tayek JA, Danese PNN, Smith MS. Tayek JA, et al. N Engl J Med. 2017 Nov 16;377(20):1994-5. doi: 10.1056/NEJMc1712575. N Engl J Med. 2017. PMID: 29143514 No abstract available.

3

Effects of long-term 4-aminopyridine therapy on glucose tolerance and glucokinetics in patients with spinal cord injury.

Segal JL, Thompson JF, Tayek JA. Segal JL, et al. Among authors: tayek ja. Pharmacotherapy. 2007 Jun;27(6):789-92. doi: 10.1592/phco.27.6.789. Pharmacotherapy. 2007. PMID: 17542761 Clinical Trial.

4

Growth hormone administration increases glucose production by preventing the expected decrease in glycogenolysis seen with fasting in healthy volunteers.

Ghanaat F, Tayek JA. Ghanaat F, et al. Among authors: tayek ja. Metabolism. 2005 May;54(5):604-9. doi: 10.1016/j.metabol.2004.12.003. Metabolism. 2005. PMID: 15877290 Clinical Trial.

5

Peroxisome proliferator-activated receptor-gamma agonist increases both low-density lipoprotein cholesterol particle size and small high-density lipoprotein cholesterol in patients with type 2 diabetes independent of diabetic control.

Bavirti S, Ghanaat F, Tayek JA. Bavirti S, et al. Among authors: tayek ja. Endocr Pract. 2003 Nov-Dec;9(6):487-93. doi: 10.4158/EP.9.6.487. Endocr Pract. 2003. PMID: 14715475 Clinical Trial.

6

A decrease in glucose production is associated with an increase in plasma citrulline response to oral arginine in normal volunteers.

Apostol AT, Tayek JA. Apostol AT, et al. Among authors: tayek ja. Metabolism. 2003 Nov;52(11):1512-6. doi: 10.1016/s0026-0495(03)00323-8. Metabolism. 2003. PMID: 14624416

7

Glucocorticoid insufficiency in patients who present to the hospital with severe sepsis: a prospective clinical trial.

Manglik S, Flores E, Lubarsky L, Fernandez F, Chhibber VL, Tayek JA. Manglik S, et al. Among authors: tayek ja. Crit Care Med. 2003 Jun;31(6):1668-75. doi: 10.1097/01.CCM.0000063447.37342.A9. Crit Care Med. 2003. PMID: 12794402 Clinical Trial.

8

Low-dose oral glyburide reduces glucose production rates in patients with impaired fasting glucose.

Bavirti S, Tayek JA. Bavirti S, et al. Among authors: tayek ja. Metabolism. 2003 Apr;52(4):407-12. doi: 10.1053/meta.2003.50068. Metabolism. 2003. PMID: 12701050 Clinical Trial.

9

Type 2 diabetic patients may have a mild form of an injury response: a clinical research center study.

Richardson AP, Tayek JA. Richardson AP, et al. Among authors: tayek ja. Am J Physiol Endocrinol Metab. 2002 Jun;282(6):E1286-90. doi: 10.1152/ajpendo.00132.2001. Am J Physiol Endocrinol Metab. 2002. PMID: 12006358 Free article.

10

Vitamin A treatment for severe sepsis in humans; a prospective randomized double blind placebo-controlled clinical trial.

Cherukuri L, Gewirtz G, Osea K, Tayek JA. Cherukuri L, et al. Among authors: tayek ja. Clin Nutr ESPEN. 2019 Feb;29:49-51. doi: 10.1016/j.clnesp.2018.10.011. Epub 2018 Nov 17. Clin Nutr ESPEN. 2019. PMID: 30661700 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results